中文摘要翻译成英文

2型病磺脲类降糖药物(Su)继发失效的发生可能与以下几个方面原因有关：q获得性p细胞对葡萄糖浓度缺乏识别能力；②磺脲类药物慢性脱敏，肝糖输出增加周围组织糖利用减少。③长期用药导致体内产生磺脲类药抗体。2型糖尿病患者许多并发症不仅与高血糖有关，而且与高胰岛素有关，且胰岛素的治疗亦被一部分患者拒绝使用或无法使用，本组应用瑞格列奈治疗2型糖尿病磺脲类药物继发失效26例，取得了较好的疗效，是因为瑞格列奈与磺脲类作用机理不同，应在β细胞上受体作用为点及亲和力和其他磺脲类药物不一致。此外，该药还被证明具有受葡萄糖反馈的调节胰岛素释放作用。因此决定了该药可用于某些继发性磺脲类药物失效的患者。

把以上中文翻译成英文，高手来，不要在线翻译的，我看的出来，100分悬赏。麻烦快点，急用，1个小时内解决追加分。谢谢

Type 2 disease sulfonylureas (Su) the occurrence of secondary failure may cause the following areas: q p cells acquired a lack of recognition of glucose concentration; ② sulfonylurea chronic desensitization, glucose output increased use of surrounding tissue to reduce sugar. ③长期用药导致体内产生磺脲类药抗体。 ③ drugs cause long-term sulfonylurea antibody production in vivo. 2型糖尿病患者许多并发症不仅与高血糖有关，而且与高胰岛素有关，且胰岛素的治疗亦被一部分患者拒绝使用或无法使用，本组应用瑞格列奈治疗2型糖尿病磺脲类药物继发失效26例，取得了较好的疗效，是因为瑞格列奈与磺脲类作用机理不同，应在β细胞上受体作用为点及亲和力和其他磺脲类药物不一致。 Many complications of type 2 diabetes and high blood sugar is not only relevant, but also related to high insulin, and insulin therapy were also part of the patients refused to use or not use, this group were repaglinide sulfonylurea treatment of type 2 diabetes secondary 26 cases of failure to obtain a good effect, because the different mechanism of repaglinide and sulfonylureas, should be the role of β cell receptor for the points and the affinity and other sulfonylureas are inconsistent. In addition, the drug also proved to be glucose, the role of feedback regulation of insulin release. It was decided the drug can be used for secondary sulfonylurea failure in some patients.

Type 2 disease sulfonylureas (Su) the occurrence of secondary failure may cause the following areas: q p cells acquired a lack of recognition of glucose concentration; ② sulfonylurea chronic desensitization, glucose output increased use of surrounding tissue to reduce sugar. ③ drugs cause long-term sulfonylurea antibody production in vivo. Many complications of type 2 diabetes and high blood sugar is not only relevant, but also related to high insulin, and insulin therapy were also part of the patients refused to use or not use, this group were repaglinide sulfonylurea treatment of type 2 diabetes secondary 26 cases of failure to obtain a good effect, because the different mechanism of repaglinide and sulfonylureas, should be the role of β cell receptor for the points and the affinity and other sulfonylureas are inconsistent. In addition, the drug also proved to be glucose, the role of feedback regulation of insulin release. It was decided the drug can be used for secondary sulfonylurea failure in some patients.

这个好专业啊，最好还是找一家像美东旭翻译公司那样的专业的公司去翻译，才比较靠谱吧？在百度上等翻译结果能理想么？

Type 2 disease sulfonylurea oral glucose-lowering drugs (SUS) secondary to the possible failure with the following aspects: q acquired reason of glucose concentrations of p cell recognition ability, 2 sulfonylureas chronic desensitization, glycogen output increased by reducing sugar surrounding tissue. Long-term use (the body produces sulfonylurea medicine antibody. Many with type 2 diabetes complications, but not only with high insulin, and with high insulin therapy was also part of the patient refused to use of, or inability to use, the application of raigor column nai causese of treatment for type 2 diabetes sulfonylureas subsequent failure in 26 cases, has good curative effect, because red nanotubes with glibenclamide sulfonylurea mechanism should be in beta cells, the receptor for points and affinity and other sulfonylureas. In addition, it is proved by the feedback with glucose release insulin regulation. So it can be used for determines some secondary sulfonylureas failure patients. The more Chinese translated into English and master, online translation, I see the reward, 100 points. Hurry up, the urgent problems to solve, 1 hours extra points. thank you